March 5, 2020 / 3:22 PM / in 25 days

BRIEF-Coherus Says U.S. Manufacturing Site Has Not Been Impacted By Coronavirus

March 5 (Reuters) - Coherus BioSciences Inc:

* UNITED STATES MANUFACTURED UDENYCA® (PEGFILGRASTIM-CBQV) WELL POSITIONED TO MEET MARKET DEMAND

* COHERUS BIOSCIENCES - U.S. MANUFACTURING & DISTRIBUTION IS WELL POSITIONED TO ENSURE UNINTERRUPTED AVAILABILITY OF UDENYCA FOR PATIENTS

* COHERUS BIOSCIENCES INC - DOES NOT SOURCE ACTIVE PHARMACEUTICAL INGREDIENTS FOR UDENYCA FROM CHINA, OR INDIA

* COHERUS BIOSCIENCES INC - MANUFACTURING SITE IN BOULDER, COLORADO HAS NOT BEEN IMPACTED BY CORONAVIRUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below